TScan Therapeutics Inc.
2.68
0.05 (1.90%)
At close: Jan 15, 2025, 2:44 PM

TScan Therapeutics Inc. Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for TCRX stock have an median target of 11, with a low estimate of 9 and a high estimate of 15. The median target predicts an increase of 310.45% from the current stock price of 2.68.

Analyst Consensus: Buy
Target Low Average Median High
Price $9 $11.4 $11 $15
Change 235.82% 325.37% 310.45% 459.70%

AI Analyst Report

HC Wainwright & Co. has reiterated a Buy rating fo... Unlock content with Pro Subscription

Updated Dec 11, 2024

Rating Apr 24May 24Jun 24Aug 24Nov 24Dec 24
Strong Buy 000000
Buy 131332
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 3 1 3 3 2

Financial Forecast this Year

Revenue This Year
3.61M
from 21.05M
Increased by -82.9%
Revenue Next Year
6.98M
from 3.61M
Increased by 93.5%
EPS This Year
-1.27
from -1.36
Increased by 6.6%
EPS Next Year
-1.28
from -1.27
Increased by -0.8%